Derma Brilliance Sunscreen SPF 30 (Allure Labs, Inc)


Welcome to the PulseAid listing for the Derma Brilliance Sunscreen SPF 30 drug offered from Allure Labs, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Allure Labs, Inc
NON-PROPRIETARY NAME: Octinoxate, Oxybenzone, Octisalate, Avobenzone and Octocrylene
SUBSTANCE NAME: OCTINOXATE; OXYBENZONE; OCTISALATE; AVOBENZONE; OCTOCRYLENE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: CREAM
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2015-03-17
END MARKETING DATE: 0000-00-00


Derma Brilliance Sunscreen SPF 30 HUMAN OTC DRUG Details:

Item DescriptionDerma Brilliance Sunscreen SPF 30 from Allure Labs, Inc
LABELER NAME: Allure Labs, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 7.5; 6; 5; 2; 1.5(mg/g; mg/g; mg/g; mg/g; mg/g)
START MARKETING DATE: 2015-03-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62742-4073_2cf57334-fa04-41f3-964d-edbe1dc8f31e
PRODUCT NDC: 62742-4073
APPLICATION NUMBER: part352

Other OCTINOXATE; OXYBENZONE; OCTISALATE; AVOBENZONE; OCTOCRYLENE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allure Labs, IncDerma Brilliance Sunscreen SPF 30
Allure Labs, Inc.Solar Moisturizer SPF 30